DURVALUMAB
Clinical trials for DURVALUMAB explained in plain language.
Never miss a new study
Get alerted when new DURVALUMAB trials appear
Sign up with your email to follow new studies for DURVALUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink hard-to-treat liver tumors
Disease control Recruiting nowThis study tests a new first-line treatment for people with advanced intrahepatic cholangiocarcinoma, a type of bile duct cancer that cannot be removed by surgery. The treatment combines chemotherapy directly into the liver artery (HAIC) with two drugs: durvalumab (an immunothera…
Matched conditions: DURVALUMAB
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New combo therapy aims to boost liver cancer survival
Disease control Recruiting nowThis phase 2 trial tests a new combination treatment for people with advanced liver cancer that cannot be removed by surgery. It combines precise proton radiation with two immunotherapy drugs, tremelimumab and durvalumab. The goal is to see if this approach is safe and works bett…
Matched conditions: DURVALUMAB
Phase: PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:22 UTC